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Gelatinous bone marrow transformation (GMT), also known as starvation marrow, represents a rare
pathological entity of unclear etiology, in which bone marrow histopathology demonstrates hypoplasia, fat
atrophy, and gelatinous infiltration. The finding of gelatinous marrow transformation lacks disease specificity;
rather, it is an indicator of severe illness and a marker of poor nutritional status, found in patients with eating
disorders, acute febrile illnesses, acquired immunodeficiency syndrome, alcoholism, malignancies, and con-
gestive heart failure. We present a middle-aged woman with a history of alcoholism, depression, and anorexia
nervosa who presented with failure to thrive and macrocytic anemia, with bone marrow examination
demonstrative of gelatinous transformation, all of which resolved with appropriate treatment. To our
knowledge, there are very few cases of GMT which have been successfully treated; thus, our case highlights
the importance of proper supportive management.
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G
elatinous bone marrow transformation (GMT)
was identified in twentieth century in autopsy
specimens of patients suffering from starvation;
hence, the alternate diagnostic terms ‘starvation marrow’
or ‘serous atrophyoffat’ (13). GMT, a rare clinicopatho-
logic entity, involvesbone marrowhypoplasia, fat atrophy,
and infiltration by gelatinous material (18). While the
exact etiology remains unclear, the reviewed literature
associates GMT with protein catabolic conditions and
severe malnourishment, including anorexia nervosa, acute
febrile states; young patients (B40) with acquired im-
munodeficiency syndrome (AIDS), alcoholism, malab-
sorption; middle-aged patients with lymphoma; and
elderly patients with carcinomas, lymphomas, and con-
gestive heart failure (18). The degree of a patient’s weight
loss may be the predominant risk factor (8, 9). This report
details the presentation of a middle-aged woman with
historyof alcoholism, depression, and anorexia nervosa
presenting with weight loss, confusion, failure to thrive,
and macrocytic anemia with gelatinous transformation
of bone marrow, and reversibility of the condition upon
receiving treatment.
Case report
A 40-year-old African American woman with a medical
history of anorexia nervosa, depression, and a documen-
ted history of iron overload syndrome presented to the
emergency department with a self-reported weight loss of
150 lbs, confusion, ambulatory dysfunction, and general-
ized weakness, all of which progressed over a period of
1 year. Approximately 5 months earlier, she had been
hospitalized for 8 weeks, having presented at that time
with weakness, weight loss (stated her baseline weight was
234 lbs and at that time weighed 118 lbs) and dysphagia,
and was diagnosed with vitamin D deficiency, niacin
deficiency, myopathy, as well as esophageal ulceration,
gastritis, and duodenal ulcer which were demonstrated
on esophagogastroduodenoscopy (EGD). She had been
discharged home with planned follow-up in 3 weeks;
however, she did not present for follow-up. She stated she
was eating an unrestricted oral diet; however, she had
previously received both enteral and parenteral nutrition
due to the severityof her malnourishment. Further review
of systems revealed absent menses for the past 3 years.
Aside from her personal historyof alcohol abuse disorder,
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tobacco, andwas in remission from alcoholism at the time
of presentation for more than 6 months.
On general examination, she appeared emaciated and
cachectic despite being within normal range of body
weight for her height, suggesting underlying obesity
with marked weight loss and malnutrition. She weighed
97 lbs and was 5 feet tall, with a body mass index of
18.9 (based on her self-reported baseline weight, this is
a 137 lb weight loss). Vital signs demonstrated only mild
sinustachycardiawithheartrateof105withoutorthostatic
changes noted. Cephalic examination revealed sunken
orbits.Keratoconjunctivaewerepale,andscleraeappeared
muddy. Oropharyngeal exam demonstrated dental ero-
sions.Cardiopulmonaryandlymphaticexaminationswere
unremarkable. Abdominal examination initially revealed
only a well-healed percutaneous endoscopic gastrostomy
(PEG) scar. Bilateral lower extremity edema was present.
Neurologic exam disclosed decreased muscle tone and
evidence of cognitive decline (SLUMS [Saint Louis Uni-
versity mental status] score was 20/30), consistent with
dementia.
Laboratory studies revealed macrocytic anemia (hemo-
globin 7.8 g/dL MCV [mean corpuscular volume] 125 fL,
reticulocyte 2.3%, red blood cell [RBC] 1.8210
12/L,
with normal white blood cell [WBC] and platelet counts,
normal folate and vitamin B12, normal iron and trans-
ferrin studies, and elevated ferritin being 1,491 ng/mL
[normal 15200 ng/mL]). Serum chemistries were unre-
markable. Total 25 hydroxy vitamin D was extremely low
at 4 ng/mL, deficient range B20 ng/mL. Thyroid studies
were within normal limits. Hepatic profile demonstrated a
normal total protein of 7.1 g/dL, low albumin of 2.4 g/dL,
slightly elevated total bilirubin of 1.2 mg/dL, elevated as-
partate transaminase of 94 U/L (normal range 032 U/L),
slightly elevated alanine transaminase of 36 (normal range
033 U/L), and elevated alkaline phosphatase of 167 U/L
(normal range 35104 U/L). Serum ammonia was mea-
sured due to her confused status and history of hepatic dis-
ease, which was slightly above normal range at 54 mmol/L
(normal range 1151mmol/L). Subsequent directbilirubin
measured 2 days later was 0.4 mg/dL (normal range 0.0
0.3 mg/dL) indicating a primarily indirect hyperbilirubi-
nemia. A viral hepatitis profile demonstrated hepatitis A
IgM antibody positivity, indicative of active hepatitis
A infection.
Neurologic investigation initially included structural
neuroimaging specialty consultation with neurology
and psychiatry services, as well as evaluation of systemic
etiologies (Lyme disease, Wilson’s disease, B12 and/or
folate deficiency, syphilis, vasculitides and rheumatologic
disease, etc.). A non-contrast CT of the head at the time
of admission showed age-inappropriate diffuse cerebral
atrophy. Magnetic resonance imaging (MRI) with fluid
attenuated inversion recovery (FLAIR), in addition to
age-inappropriate atrophy already demonstrated on CT,
showed a few scattered foci of increased T2 and FLAIR
(Fig. 1) signal in the subcortical white matter bilaterally
which are non-specific. Erythrocyte sedimentation rate
(ESR) was significantly elevated at 130 mm/h (normal
range 020 mm/h), and rheumatoid factor was positive
with a titer above 1:4, suggesting an inflammatory or
possiblyautoimmuneprocess.Otherbiomarkersincluding
anti-nuclear antibodies (ANA), lyme titer, RPR, folate,
vitamin B12, serum copper and ceruloplasmin, as well as
humanimmunodeficiencyvirus(HIV)1and2ELISAwere
non-reactive. Electromyelography (EMG) with nerve con-
duction studies (NCS) demonstrated bilateral lower ex-
tremity myopathy without evidence of demyelinating
disease.
Fig. 1. Axial CT and Sagittal MRI of the brain show
signiﬁcant age-inappropriate diffuse cerebral atrophy.
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included functional neuroimaging and genetics testing.
Single photon emission computer tomography (SPECT)
imaging was done, but revealed no additional diagnostic
findings. Testing for early Alzheimer’s associated gene
mutations was also negative.
Abdominopelvic CT without IV contrast (Fig. 2) was
obtained,whichdemonstratedmarkedasciteswithanasarca,
and a small fatty liver. Further laboratory studies included
serum alpha-fetoprotein, human hemochromatosis protein
(HFE) gene, ceruloplasmin, anti-liverkidneymuscle (anti-
LKM) antibody, and serum prealbumin, all of which were
unremarkable except low prealbumin (14 mg/dL [normal
1845 mg/dL]), which is a more specific markerof protein
malnutrition than albumin. During the hospital course, the
patient gradually manifested significant ascites on physical
examination. Further research into the patient’s medical
chart from her previous hospitalization at another facility
Fig. 2. CT of the abdomen with oral contrast shows marked hepatic steatosis and ascites.
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examination had not revealed any additional diagnosis, and
thehepaticironindexwas1.9(hepaticironindexabove1.9in
a patient without liver failure suggests hemochromatosis 
giventheabnormalitiesnotedinhepaticfunction,anindexof
1.9 was not considered diagnostic for hemochromatosis).
The patient’s significant macrocytic anemia was also
investigated. The folate, vitamin B12, and normal thyroid
studies were all normal, and the patient reported being
completely abstinent from alcohol in the recent past; there-
fore, the etiology was unclear. During the hospitalization,
her anemia became increasingly severe, falling below 7
and requiring transfusion of packed RBCs. No evidence
of a bleeding source or intravascular erythrocyte destruc-
tion was found. Hematology performed a bone marrow
biopsy. Bone marrow histopathology and flow cytometry
revealed infiltration by gelatinous substance, fat atrophy
and marrow hypocellularity (Fig. 3), with normal female
karyotype and no evidence of occult malignancy.
During the hospital course, her management consisted
primarily of supportive care. She was hydrated intrave-
nously until shebecame euvolemic andwas able to achieve
adequate oral intake of fluids. Her macro and micronu-
trient deficiencies were addressed and repleted. She re-
ceived megestrol, which works through various hormonal
pathways including glucocorticoid and gonadotropic
stimulation, and at doses between 400 and 800 mg daily
has been shown to improve appetite and oral intake in
patients with anorexia. There was significant impro-
vement in her appetite, and she tolerated a calorically
adequate oral diet, which was supplemented by multi-
vitamins, zinc, folic acid, and vitamin D. She was also
treated pharmacologically with sertraline 100 mg daily,
and non-pharmacologically with physical therapy and
counseling. Her caloric intake improved as evidenced by
improved prealbumin and body weight.
Once she became medically stable, she was transferred
to the psychiatric unit, as her depression and severe cog-
nitive deficits had only minimally improved and was not
suitable for discharge. Over the next month and a half,
she slowly improved, and appropriate outpatient sup-
port services were arranged. Her treatment was properly
maintained for the next 6 months, and her follow-up
examination at this time demonstrated marked clinical
improvement, significant resolution of her neurocognitive
deficits, as well as a rise in hemoglobin to 11.5 g/dL with
normalization of RBC indices (i.e., MCV).
Discussion
The above case represents a young female with severe
malnutrition presenting with hypoproliferative macrocy-
tic anemia, aswell as hepatic disease and neuropsychiatric
impairment. The pathologic lesion ultimately identified
was GMT. Her severe anemia improved once she received
appropriate nutritional and supportive management.
Interestingly, the patient’s body mass index was not
particularly low on presentation. However, she did appar-
ently lose 137 lbs in less than a year (53% weight loss).
A small retrospective study published in 2002 correlating
bone marrow changes and clinical factors in patients
with eating disorders found that the amount of weight
loss alone correlated with bone marrow changes, with no
Fig. 3. Pathologic examination of bone marrow demonstrating focal gelatinous substance (arrows), consistent with ‘starvation’
bone marrow.
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other clinical factors (9).
Whether GMT was fully or partially responsible for
any components of the patient’s hematologic, hepatic, or
neurocognitive presentation is unknown. Her liver disease
certainly could have been related to a self-limited hepatitis
A infection, as well as being a manifestation of her se-
vere protein malnutrition. The cause of her severe cerebral
atrophy is unclear. Macrocytic anemia has been described
in the literature as associated with GMT; however, cau-
sality versus association has not been clearly elucidated.
Nevertheless, GMT is a very rare finding, and typically
occurs in young adult males with severe malnutrition
(1, 4). While still unclear, the purported pathophysiology
involves deposition of gelatinous substance in bone
marrow to replace adipose cells which are systemically
depleted due to severe catabolism (1, 3, 5). Mucopoly-
saccharides enriched with hyaluronic acid comprises this
gelatinous substance deposition, rendering the bone
marrow microenvironment unfavorableforerythropoiesis,
(3, 5, 6) although degree of GMT and severity of anemia
have not been shown to be concordant (1, 2). Though the
lesion is mostly associated with chronic wasting diseases,
few patients with malnutrition develop GMT, therefore,
additional factors likely play a role in its pathogenesis
(1, 3). While the condition should theoretically reverse
upon adequately treating the underlying cause (1, 2, 4,
5, 7), few cases of successful reversal of GMT have been
published.
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